Soleno Therapeutics (6XC.F) Q3 2025 Earnings

Aug 6Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.68
-1.15
-0.61
-0.08

Details

Expected EPS
-0.38869678086
Actual EPS
-0.0771678
Surprise EPS
0.31
Surprise Percent
+80.15%

Description

⁨Soleno Therapeutics⁩ (⁦6XC.F⁩) has reported earnings of ⁦-0.0771678⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts